Issues related to disposable negative pressure wound therapy, including related to maternal health. Issues related to the Physician Fee Schedule (PFS), including payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Issues related to reporting of Average Sales Price for skin substitutes. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. H.R.7024, Tax Relief for American Families and Workers Act of 2024, as it relates to the R&D credit and interest expense deduction. Monitor H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.
Monitored issues related to pressure injuries. Issues related to medical device shortage reporting.
Issues related to the sterilization of medical devices.
Duration: November 17, 2014
to
present
General Issues: Medicare/Medicaid , Taxation/Internal Revenue Code , Health Issues , Budget/Appropriations , Government Issues , Trade (Domestic & Foreign)
Spending: about $1,931,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Stacey Hughes U.S. Senate Budget Committee, Deputy Staff Director
Office of the Asst. Maj. Leader (Sen. Nickles), Policy Adv.
Office of the Asst. Min. Leader (Sen. Nickles), Policy Adv.
Senate Spec. Cmte on Aging (Sen Cohen), Prof. Staff Member
U.S. Senator Connie Mack, Leg. Asst / Scheduler
Emily Porter Ofce of Spkr(Rep.Boehner),Asst to Spkr for Policy
Ofce of Min. Leader (Rep.Boehner), Policy Adv.
Ofce of the Maj. Leader (Rep. Boehner),Policy Adv
Cmte on Ed & the Wrkfrc (Rep.Boehner),Coalitions Dir. for Ed
Rep. Trent Franks, Sr. Leg. Asst.
Rep. Tom Tancredo, Leg. Asst.
Ofce of Spkr(Rep.Boehner),Asst to Spkr for Plcy
Ofce of the Maj. Leader (Rep. Boehner),Pol. Adv.
(continued) Coalitions Dir. for Educ. Policy
Rachel Jones Hensler U.S. Senate Budget Committee, Tax Policy Dir.; Office of U.S. Senator Fred Thompson, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Correspondent
Jeff Choudhry U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern
Greg D'Angelo White House Office of Management and Budget, Associate Director of Health Programs;
Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member.
Brett Baker U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff
Mary Beth Savary Taylor Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 19.
Original Filing: 301567438.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy, including related to maternal health. Issues related to the Physician Fee Schedule (PFS), including payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Issues related to reporting of Average Sales Price for skin substitutes. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. H.R.7024, Tax Relief for American Families and Workers Act of 2024, as it relates to the R&D credit and interest expense deduction. Monitor H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to pressure injuries. Issues related to medical device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the sterilization of medical devices.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 17.
Original Filing: 301526301.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy, including related to maternal health. Issues related to Physician Fee Schedule (PFS), including payment for skin substitutes wound treatments and tympanostomy procedures. Skin substitutes wound treatments as it relates to Medicare local coverage decisions. Issues related to reporting of Average Sales Price for skin substitutes. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. S. 866, the American Innovation and Jobs Act, as it relates to the R&D tax credit. H.R. 3938, Build It in America Act, as it relates to the R&D credit and interest expense deduction. H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to pressure injuries. Issues related to medical device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the sterilization of medical devices.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 18, 2023.
Original Filing: 301505176.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy, including related to maternal health. Issues related to Physician Fee Schedule (PFS), including payment for skin substitutes wound treatments and tympanostomy procedures. Skin substitutes wound treatments as it relates to Medicare local coverage decisions. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. S. 866, the American Innovation and Jobs Act, as it relates to the R&D tax credit. H.R. 3938, Build It in America Act, as it relates to the R&D credit and interest expense deduction. H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to pressure injuries. Issues related to medical device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the sterilization of medical devices.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 18, 2023.
Original Filing: 301480560.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy. Issues related to Physician Fee Schedule (PFS), including payment for skin substitutes wound treatments and tympanostomy procedures. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. S. 866, the American Innovation and Jobs Act, as it relates to the R&D tax credit. H.R. 3938, Build It in America Act, as it relates to the R&D credit and interest expense deduction. H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pressure injuries. Issues related to medical device shortage reporting.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to treatment of pressure injuries in Veterans Health Administration facilities.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301460160.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy. Issues related to Physician Fee Schedule (PFS), including payment for skin substitutes would treatments and tympanostomy procedures. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to health care. Monitored issues related to pass-through payments for medical devices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. Monitor S. 866, the American Innovation and Jobs Act, and issues related to the R&D tax credit.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pressure injuries.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to treatment of pressure injuries in Veterans Health Administration facilities.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429730.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored the implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to health care. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to Medicare separate payment for disposable negative pressure wound therapy devices. Issues related to calendar year 2023 Physician Fee Schedule (PFS) Rule, including payment for skin substitutes wound treatments.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to corporate and international taxes. Monitor H.R. 1304, the American Innovation and R&D Competitiveness Act; S. 749, the American Innovation and Jobs Act; and issues related to the R&D tax credit. Monitor H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to medical device shortages. Issues related to FDA inspections of manufacturing facilities.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 18, 2022.
Original Filing: 301408193.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to health care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to corporate and international taxes. Monitor H.R. 1304, the American Innovation and R&D Competitiveness Act; S. 749, the American Innovation and Jobs Act; and issues related to the R&D tax credit.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
S. 4348, FDASLA Act of 2022 / H.R. 7667, Food and Drug Amendment of 2022, as they relate to medical devices.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 19, 2022.
Original Filing: 301385842.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Build Back Better Act, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the status of H.R. 7108, Suspending Normal Trade Relations with Russia and Belarus Act.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
S. 4348, FDASLA Act of 2022 / H.R. 7667, Food and Drug Amendment of 2022, as they relate to medical devices.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 19, 2022.
Original Filing: 301361458.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Build Back Better Act, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the status of H.R. 7108, Suspending Normal Trade Relations with Russia and Belarus Act.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
S. 3799, PREVENT Pandemics Act, as it relates to medical device supply chains and shortages.
4th Quarter, 2021
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301333712.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S. 2164, the Lower Costs, More Cures Act. Monitored H.R. 3684 (P.L. 117-58), the Infrastructure Investment and Jobs Act, as it relates to health care. H.R. 5376, the Build Back Better Act, as it relates to health care. Monitored S. 610 (P.L. 117-71), the Protecting Medicare and American Farmers from Sequester Cuts Act, as it relates to Medicare sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Build Back Better Act, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored S.Con.Res. 14, FY 2022 Budget Resolution.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored issues related to Medicare sequestration. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, the Lower Costs, More Cures Act. Monitored FY 2022 Budget Resolution. Monitored H.R. 3684 (P.L. 117-58), the Infrastructure Investment and Jobs Act, as it relates to health care. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301308920.xml
Lobbying Issues
S. 2363/H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored issues related to Medicare sequestration. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S. 2164, the Lower Costs, More Cures Act. Monitored H.R. 3684, the Infrastructure Investment and Jobs Act, as it relates to health care. H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Build Back Better Act, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored S.Con.Res. 14, FY 2022 Budget Resolution.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored issues related to Medicare sequestration. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, the Lower Costs, More Cures Act. Monitored FY 2022 Budget Resolution. Monitored H.R. 3684, the Infrastructure Investment and Jobs Act, as it relates to health care. Monitored H.R. 5376, the Build Back Better Act, as it relates to health care.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301285744.xml
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored issues related to Medicare sequestration. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S. 2164, the Lower Costs, More Cures Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
The American Jobs Plan, as it relates to corporate and international taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored FY 2022 Budget Resolution.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2356, Better Wound Care at Home Act and issues related to disposable negative pressure wound therapy. Monitored issues related to pass-through payments for medical devices. Monitored issues related to Medicare sequestration. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, the Lower Costs, More Cures Act. Monitored FY 2022 Budget Resolution.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 16, 2021.
Original Filing: 301254263.xml
Lobbying Issues
Issues related to disposable negative pressure wound therapy; issues related to teleheath; monitored P.L. 117-2, the American Rescue Plan. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1868, Medicare Sequester Bill and S. 748, Medicare Sequester Relief Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
P.L. 117-2, the American Rescue Plan, as it relates to interest allocation rules. The American Jobs Plan, as it relates to corporate taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored FY'21 Budget Resolution.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 20, 2021.
Original Filing: 301242661.xml
Lobbying Issues
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); monitored issues related to the Most Favored Nation (MFN) rule. H.R. 133, the Consolidated Appropriations Act of 2021, and issues related to health extenders.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor implementation of The Tax Cut and Jobs Act, as it relates to multinational corporations. H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to corporate taxes.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; H.R. 133, the Consolidated Appropriations Act of 2021.
3rd Quarter, 2020
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 18, 2020.
Original Filing: 301213073.xml
Lobbying Issues
Issues related to drug pricing and pass through payment; issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored issues related H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $40,000. The report was filed on July 20, 2020.
Original Filing: 301196473.xml
Lobbying Issues
Monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored issues related to the regulation of medical devices.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301173937.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act regarding interest expensing; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2019
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Jan. 21, 2020.
Original Filing: 301126273.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act; HR 88 and issues related to the medical device tax. H.R. 3301, Taxpayer Certainty and Disaster Tax Relief Act of 2019, as it relates to repeal of the medical device tax; H.R. 1865, Further Consolidated Appropriations Act, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2019
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068763.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act; HR 88 and issues related to the medical device tax. H.R. 3301, Taxpayer Certainty and Disaster Tax Relief Act of 2019, as it relates to repeal of the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2019
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on July 22, 2019.
Original Filing: 301057833.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act; HR 88 and issues related to the medical device tax. H.R. 3301, Taxpayer Certainty and Disaster Tax Relief Act of 2019, as it relates to repeal of the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2019
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $50,000. The report was filed on April 19, 2019.
Original Filing: 301030993.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to the reimbursement of skin substitutes; issues related to disposable negative pressure wound therapy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act; HR 88 and issues related to the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to the conference report accompanying H.J. Res 31.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Jan. 18, 2019.
Original Filing: 301010511.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to the reimbursement of skin substitutes; issues related to disposable negative pressure wound therapy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act; HR 88 and issues related to the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989797.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to the reimbursement of skin substitutes; issues related to disposable negative pressure wound therapy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act.
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on July 20, 2018.
Original Filing: 300973254.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to the reimbursement of skin substitutes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Tax Cut and Jobs Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 4170, the Disclosing Foreign Influence Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on April 20, 2018.
Original Filing: 300955743.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers; issues regarding reimbursement for skin substitutes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.Con.Res 71 and issues related to corporate tax reform. Monitored H.R. 1892, Bipartisan Budget Act of 2018; H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare prescription drug reimbursements.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936223.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to unique device identifiers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1, The Tax Cut and Jobs Act, as it relates to corporate tax reform and the taxation of multinational companies; issues related to the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.Con.Res 71 and issues related to corporate tax reform; H.R.1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 and paygo & CHIP.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Oct. 19, 2017.
Original Filing: 300909311.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; issues related to S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor issues related to corporate tax reform and the taxation of multinational companies; issues related to the medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2017
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on July 19, 2017.
Original Filing: 300891483.xml
Lobbying Issues
Issues related to unique device identifiers; monitored issues related to drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, the American Health Care Act of 2017; issues related to S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor issues related to corporate tax reform and the taxation of multinational companies.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2017
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on April 20, 2017.
Original Filing: 300875730.xml
Lobbying Issues
Issues related to unique device identifiers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, the American Health Care Act of 2017.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to S. Con. Res. 3, FY '17 Budget Resolution.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855942.xml
Lobbying Issues
Issues related to unique device identifiers (UDI's); issues concerning the implementation of access to disposable medical technology; issues concerning Medicaid Rebate policies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored issues related to H.R.34, The 21st Century Cures Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835841.xml
Lobbying Issues
Issues related to unique device identifiers (UDI's); issues concerning the implementation of access to disposable medical technology; issues related to severe wounds; issues concerning Medicaid Rebate policies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored issues related to H.R.6, The 21st Century Cures Act and the Innovation Initiative.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on July 18, 2016.
Original Filing: 300811406.xml
Lobbying Issues
Issues related to unique device identifiers (UDI's); issues concerning the implementation of access to disposable medical technology; issues related to severe wounds; issues concerning Medicaid Rebate policies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Cures Act and the innovation initiative.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on April 20, 2016.
Original Filing: 300798350.xml
Lobbying Issues
Issues related to unique device identifiers (UDI's); issus concerning the implementation of access to disposable medical technology; issues related to severe wounds.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Cures Act and the innovation initiative.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2015
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Jan. 20, 2016.
Original Filing: 300778405.xml
Lobbying Issues
Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Cures Act and issues related to disposable medical devices.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 34, the Tax Increase Prevention and Real Estate Investment Act of 2015 and H.R. 2029, Consolidated Appropriations Act, 2016 as it relates to medical device tax and disposable medical devices.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764061.xml
Lobbying Issues
Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Cures Act and issues related to disposable medical devices.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on July 20, 2015.
Original Filing: 300741515.xml
Lobbying Issues
Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Act and issues related to disposable medical devices.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
THE NICKLES GROUP, LLC amended a lobbying report for representation of Smith & Nephew, Inc. in Q22015 on July 20, 2015.
Original Filing: 300743358.xml
Lobbying Issues
Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6, The 21st Century Cures Act and issues related to disposable medical devices.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $54,000. The report was filed on April 20, 2015.
Original Filing: 300722437.xml
Lobbying Issues
Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the 21st Century Cure Initiatives related to disposable medical devices.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2014
In Q4, THE NICKLES GROUP, LLC lobbied for Smith & Nephew, Inc. , earning $27,000. The report was filed on Jan. 20, 2015.
Original Filing: 300705260.xml
Lobbying Issues
Issues related to disposable medical technologies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to the 21st Century Cure Initiatives related to medical devices.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...